<DOC>
	<DOCNO>NCT00003054</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness paclitaxel treat patient recurrent persistent cancer uterus .</brief_summary>
	<brief_title>Paclitaxel Treating Patients With Recurrent Persistent Cancer Uterus</brief_title>
	<detailed_description>OBJECTIVES : I . Estimate antitumor activity paclitaxel patient metastatic persistent leiomyosarcoma uterus fail treatment protocol high priority . II . Determine nature degree toxic effect paclitaxel group patient . OUTLINE : Patients receive continuous infusion paclitaxel every 3 week 3 hour . Patients complete remission , partial remission , stable disease undergo least 3 course paclitaxel . Paclitaxel continue disease progression adverse effect prohibit treatment . All patient follow death . PROJECTED ACCRUAL : This study anticipate annual accrual approximately 25 patient 2.5 year .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Leiomyosarcoma</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm recurrent persistent uterine leiomyosarcoma refractory curative therapy establish treatment Measurable disease require Must fail local therapeutic measure must consider incurable Not eligible GOG protocols high priority PATIENT CHARACTERISTICS : Age : Not specify Performance status : GOG 03 Life expectancy : Not specify Hematopoietic : WBC least 3,000/mm3 Platelet count least 100,000/mm3 Granulocyte count least 1,500/mm3 Hepatic : Bilirubin great 1.5 time normal SGOT alkaline phosphatase great 3 time normal Renal : Creatinine great 2.0 mg/dL Cardiovascular : No unstable angina within 6 month OR No myocardial infarction within 6 month Abnormal cardiac condition ( e.g. , bundle branch block , heart block ) allow stable 6 month Other : No significant infection No concomitant malignancy nonmelanomatous skin cancer PRIOR CONCURRENT THERAPY : At least 3 week since prior therapy malignant tumor Biologic therapy : Not specify Chemotherapy : Recovery prior chemotherapy require No 1 prior chemotherapy regimen allow No prior paclitaxel No prior chemotherapy malignancy patient diseasefree least 5 year Endocrine therapy : Not specify Radiotherapy : Recovery prior radiation therapy require No prior radiation therapy malignancy patient diseasefree least 5 year Surgery : Recovery prior surgery require</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2003</verification_date>
	<keyword>recurrent uterine sarcoma</keyword>
	<keyword>uterine leiomyosarcoma</keyword>
</DOC>